N. Olivieri

发表

Identification of a novel β0 ‐ thalassaemia mutation in a greek family and subsequent prenatal diagnosis

N. Olivieri, D. Chui, B. Eng, 1994, Prenatal Diagnosis.

Clinical use of the Medication Event Monitoring System: A new window into pediatric compliance

G. Koren, D. Matsui, M. Braudo, 1992, Clinical pharmacology and therapeutics.

Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one in patients with thalassemia

G. Koren, P. St-Louis, D. Matsui, 1991, Clinical pharmacology and therapeutics.

Fetal haemoglobin augmentation in E/β0 thalassaemia: clinical and haematological outcome

D. Weatherall, E. Vichinsky, N. Olivieri, 2005, British journal of haematology.

Iron-chelating therapy and the treatment of thalassemia.

G. Brittenham, N. Olivieri, G M Brittenham, 1997, Blood.

The Psychosocial Burden of Cooley's Anemia in Affected Children and Their Parents

Arjune Sen, N. Klein, B. Modell, 1998, Annals of the New York Academy of Sciences.

Brief report: combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia.

D. Templeton, N. Olivieri, P. Daly, 1994, The New England journal of medicine.

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.

E. Chew, R. Harrison, M. Freedman, 1986, The New England journal of medicine.

Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols.

J. Dick, G. Stamatoyannopoulos, Qiliang Li, 1995, Human molecular genetics.

Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation.

D. Manson, H. O'brodovich, A. Zipursky, 1992, Pediatric hematology and oncology.

Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia.

S. Feig, M. Freedman, L. Valentino, 1994, Blood.

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.

D. Faller, H. Witkowska, N. Olivieri, 1993, The New England journal of medicine.

Use of a Eutectic Mixture of Local Anesthetics for Prolonged Subcutaneous Drug Administration

G. Koren, M. Berkovitch, D. Matsui, 1995, Journal of clinical pharmacology.

Stroke prevention trial in sickle cell anemia.

M A Waclawiw, R J Adams, Scott T. Miller, 1998, Controlled clinical trials.

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.

K. Fleming, C. McLaren, G. Brittenham, 1998, The New England journal of medicine.

Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

G. Koren, G. Brittenham, R. Cameron, 1995, The New England journal of medicine.

Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

Scott T. Miller, R. Adams, E. Vichinsky, 1995, The Journal of pediatrics.

Prevalence of fractures among the Thalassemia syndromes in North America.

E. Neufeld, E. Vichinsky, N. Olivieri, 2006, Bone.

The β-Thalassemias

D. Weatherall, N. Olivieri, 1999 .

Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.

N. Olivieri, J. Little, G. Dover, 1995, The New England journal of medicine.

Haemoglobin E β thalassaemia in Sri Lanka

TEA Peto, D. Weatherall, V. Viprakasit, 2005, The Lancet.

Genetic determinants of jaundice and gallstones in haemoglobin E β thalassaemia

D. Weatherall, C. Fisher, A. Premawardhena, 2001, The Lancet.

Secondary iron overload.

N. Olivieri, J. Kushner, J. Porter, 2001, Hematology. American Society of Hematology. Education Program.

Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.

D. Faller, E. Vichinsky, N. Olivieri, 1994, The American journal of pediatric hematology/oncology.

Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.

D. Templeton, N. Olivieri, J. G. Parkes, 1995, Biochimica et biophysica acta.

Progression of iron overload in sickle cell disease.

N. Olivieri, N. Olivieri, 2001, Seminars in hematology.

Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major.

M. Freedman, N. Olivieri, F. Holland, 1990, The New England journal of medicine.

The therapeutic reactivation of fetal haemoglobin.

D J Weatherall, D. Weatherall, N. Olivieri, 1998, Human molecular genetics.

Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.

G. Brittenham, D. Weatherall, N. Olivieri, 2000, Journal of pediatric hematology/oncology.

Single and Combination Drug Therapy for Fetal Hemoglobin Augmentation in Hemoglobin E‐β0‐Thalassemia: Considerations for Treatment

D. Weatherall, E. Vichinsky, N. Olivieri, 2005, Annals of the New York Academy of Sciences.

Methods for Noninvasive Measurement of Tissue Iron in Cooley's Anemia

T. Brown, Haiying Tang, J. Jensen, 2005, Annals of the New York Academy of Sciences.

Elimination of Transfusions Through Induction of Fetal Hemoglobin Synthesis in Cooley's Anemia a

G. Brittenham, D. Weatherall, S. Thein, 1998, Annals of the New York Academy of Sciences.

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report

E. Neufeld, J. Boudreaux, F. Trachtenberg, 2011 .

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report

E. Neufeld, J. Boudreaux, F. Trachtenberg, 2011 .

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report

E. Neufeld, J. Boudreaux, F. Trachtenberg, 2011 .

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report

E. Neufeld, J. Boudreaux, F. Trachtenberg, 2011 .